Search Results

A new survey finds widespread support for drug price reform to address the most significant threats to affordability.

As the election nears, here is a brief breakdown of what Trump has done — and has not done — on some key health issues.

Here are a few pandemic-specific changes to keep in mind to help employees act as informed health care consumers as COVID-19 continues to unfold.

The latest data suggests employers and private insurers pay 247% of what Medicare pays for the same services.

A new guidebook identifies 49 drugs with less expensive alternatives that could be cut from the lists of drugs covered by employers.

With tensions high over health care costs, brokers have gained a reputation as the bearers of bad news. Let's consider how we break that stigma.

Reference-based pricing, once considered a non-traditional option, is getting renewed attention amid the economic downturn.

To understand why COBRA premium subsidies are so essential, one need only look at the projected decline in employer-sponsored coverage.